Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) are the two main types of lung cancer. Most lung ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Lazcluze (lazertinib) for adults with non-small ...

Non-small cell lung cancer that has metastasized may cause different symptoms depending on where it has spread. Treatment can help reduce symptoms and prolong life. Non-small cell lung cancer ...

When Coretta received a diagnosis of stage 4 non-small cell lung cancer (NSCLC), she was shocked. Thanks to her oncologists, they established a care plan together. Having her treatment plan underway ...

Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...

The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or metastatic non–small cell lung cancer (NSCLC) naive to ALK treatment.

Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling. My life has changed ...

More information: Ling Cai et al, High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non–Small Cell Lung Cancer in Patients, Cancer Discovery (2025). DOI: 10.1158/2159-8290.CD ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic ...